ITC Seeks Comments on Another Section 337 Complaint on Hydrodermabrasion Systems
The International Trade Commission seeks comments by Aug. 22 on another Section 337 complaint filed by HydraFacial seeking to ban imports of hydrodermabrasion systems that allegedly infringe on its patents, the ITC said Aug. 14. This time, in a complaint…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
filed Aug. 8, HydraFacial says Germany-based MirAmedtech and its Polish and U.S. affiliates are manufacturing and importing the Cleopatra and MIRApeel systems, which infringe on patents related to HydroFacial’s Syndeo hydrodermabrasion system. The complaint also targets Medical Purchasing Resource (MPR), which distributes the Cleopatra system, as well as Clarion, Luvo and Healthcare Markets (d/b/a Powered by MRP), which distribute Eunsung’s Bela MD hydrodermabrasion system. Eunsung isn’t named in the complaint, though it’s the subject of a Section 337 investigation the ITC began in July (see 2407170007), also at HydroFacial’s request (see 2406130048).